. 2003 Aug 20;100(19):10942–10947. doi: 10.1073/pnas.1731272100

Table 1. Biodistribution of i.v. injected ^99mTc-18B7 and ^99mTc-MOPC21 antibodies at 24 h postinjection in mice intratracheally infected with CN and healthy BALB/c mice.

	Mice
Organ	Infected with CN, ^99mTc-18B7 injection	Infected with CN, ^99mTc-MOPC21 injection	Infected with CN and pretreated with 1 mg of nonradioactive 18B7 before ^99mTc-18B7 injection	Healthy controls, ^99mTc-18B7 injection
Blood	12.77 (1.22)	9.02 (2.13)	8.25 (0.22)	8.0 (0.70)
Liver	8.71 (1.22)	1.27 (0.34)	6.71 (0.52)	4.77 (0.32)
Kidney	9.88 (0.21)	3.07 (1.00)	7.26 (0.28)	4.47 (1.31)
Spleen	4.86 (0.14)	1.50 (0.09)	2.53 (0.54)	2.56 (0.62)
Stomach	2.43 (0.08)	1.04 (0.33)	5.39 (1.32)	1.57 (0.35)
Lungs	10.27 (1.02)	2.66 (0.50)	4.57 (0.33)	4.57 (0.59)

Results were obtained from n = 3 mice per time point and were tabulated as percent initial dose per g. Numbers in parentheses are SD.

Table 1. Biodistribution of i.v. injected 99mTc-18B7 and 99mTc-MOPC21 antibodies at 24 h postinjection in mice intratracheally infected with CN and healthy BALB/c mice.